Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nymox Pharmaceutical Corporation NYMXF

Full chart Compare
Set alert

Price alert · NYMXF

All alert types
0.02 USD 0.00 (+0.00%)

Nov 6, 2026, 3:04 PM EST

0.02 Day range 0.02
0.0002 52-week range 0.15
YTD
-50.25%
1 year
-78.08%

Financial health

Altman Z-Score

-506.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.9×
FY 2016: -9.5×FY 2017: -12.7×FY 2018: -7.3×FY 2019: -11.6×FY 2020: -15.5×FY 2021: -8.7×FY 2022: -4.3×FY 2023: -6.1×FY 2024: -2.1×FY 2025: -0.9×
FY 2016 5y median -4.3× FY 2025
P/S 0.0×
FY 2016: 434×FY 2017: 776×FY 2018: 265×FY 2019: 1306×FY 2020: 36616×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -0.4×
FY 2016: -509×FY 2017: -326×FY 2018: 10.1×FY 2019: 37.5×FY 2020: 67.0×FY 2021: 1284×FY 2022: -59.3×FY 2023: -17.0×FY 2024: -1.4×FY 2025: -0.4×
FY 2016 5y median -1.4× FY 2025
P/FCF -2.1×
FY 2016: -27.4×FY 2017: -28.0×FY 2018: -10.1×FY 2019: -20.4×FY 2020: -18.2×FY 2021: -10.8×FY 2022: -5.5×FY 2023: -13.3×FY 2024: -3.6×FY 2025: -2.1×
FY 2016 5y median -5.5× FY 2025
EV/EBITDA -1.1×
FY 2016: -9.5×FY 2017: -13.1×FY 2018: -6.7×FY 2019: -11.2×FY 2020: -15.4×FY 2021: -8.5×FY 2022: -4.2×FY 2023: -6.2×FY 2024: -2.2×FY 2025: -1.1×
FY 2016 5y median -4.2× FY 2025
EV/Sales 0.0×
FY 2016: 430×FY 2017: 772×FY 2018: 238×FY 2019: 1262×FY 2020: 35979×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -46.8%
FY 2016: -3.7%FY 2017: -3.6%FY 2018: -9.9%FY 2019: -4.9%FY 2020: -5.5%FY 2021: -9.2%FY 2022: -18.2%FY 2023: -7.5%FY 2024: -27.8%FY 2025: -46.8%
FY 2016 5y median -18.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 38.0%FY 2017: 33.0%FY 2018: 52.8%FY 2019: 42.2%FY 2020: -160.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -4531.7%FY 2017: -5908.5%FY 2018: -3558.9%FY 2019: -11487.1%FY 2020: -234400.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -4616.2%FY 2017: -5995.1%FY 2018: -3543.1%FY 2019: -11346.6%FY 2020: -234760.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 45.9%
FY 2016: 5417.4%FY 2017: 2519.5%FY 2018: -134.6%FY 2019: -326.0%FY 2020: -429.3%FY 2021: -15104.8%FY 2022: 1364.3%FY 2023: 278.7%FY 2024: 66.3%FY 2025: 45.9%
FY 2016 5y median 66.3% FY 2025
ROIC 39.5%
FY 2016: -1867.9%FY 2017: 2483.1%FY 2018: -135.2%FY 2019: -318.5%FY 2020: -355.7%FY 2021: -2638.0%FY 2022: 2152.8%FY 2023: 344.6%FY 2024: 63.2%FY 2025: 39.5%
FY 2016 5y median 63.2% FY 2025
ROA -742.2%
FY 2016: -637.3%FY 2017: -791.3%FY 2018: -118.4%FY 2019: -216.6%FY 2020: -238.0%FY 2021: -617.0%FY 2022: -404.7%FY 2023: -1410.5%FY 2024: -686.9%FY 2025: -742.2%
FY 2016 5y median -686.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: -21.1%FY 2018: 33.5%FY 2019: -61.2%FY 2020: -95.7%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 14.1%
FY 2016: 0.0%FY 2017: -2.8%FY 2018: 19.6%FY 2019: -25.2%FY 2020: 12.0%FY 2021: -6.7%FY 2022: 46.8%FY 2023: -25.5%FY 2024: 48.7%FY 2025: 14.1%
FY 2016 FY 2025
EPS (diluted) 7.3%
FY 2016: 0.0%FY 2017: 7.1%FY 2018: 30.8%FY 2019: -5.6%FY 2020: 15.8%FY 2021: 6.3%FY 2022: 50.9%FY 2023: -31.1%FY 2024: 50.3%FY 2025: 7.3%
FY 2016 FY 2025
Free Cash Flow 30.5%
FY 2016: 0.0%FY 2017: -37.8%FY 2018: -26.3%FY 2019: 5.2%FY 2020: -35.3%FY 2021: 2.2%FY 2022: 47.0%FY 2023: 22.0%FY 2024: 35.9%FY 2025: 30.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 1.5×FY 2017: 0.4×FY 2018: 7.5×FY 2019: 2.6×FY 2020: 2.1×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2016: 1.5×FY 2017: 0.4×FY 2018: 7.4×FY 2019: 2.6×FY 2020: 2.1×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2016: -3.8×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 4.7×FY 2022: -0.4×FY 2023: -0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.8×FY 2019: 0.4×FY 2020: 0.3×FY 2021: 0.0×FY 2022: 0.2×FY 2023: -0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Interest Coverage -6.3×
FY 2016: -55.0×FY 2017: -64.9×FY 2018: -591×FY 2019: -351×FY 2020: -279×FY 2021: -321×FY 2022: -155×FY 2023: -137×FY 2024: -19.0×FY 2025: -6.3×
FY 2016 5y median -137× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31